Us Bancorp \De\ Exact Sciences Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Exact Sciences Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 144,693 shares of EXAS stock, worth $8.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

144,693

Previous 155,442 6.92%

Holding current value

$8.41 Million

Previous $6.57 Million 50.02%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$42.43 - $70.83 $456,080 - $761,351	-10,749 Reduced 6.92%	144,693 $9.85 Million
Q2 2024 Aug 06, 2024	SELL	$41.33 - $74.26 $746,833 - $1.34 Million	-18,070 Reduced 10.41%	155,442 $6.57 Million
Q1 2024 May 07, 2024	SELL	$56.27 - $73.77 $1.73 Million - $2.27 Million	-30,727 Reduced 15.04%	173,512 $12 Million
Q4 2023 Feb 09, 2024	SELL	$59.06 - $75.72 $1.32 Million - $1.69 Million	-22,357 Reduced 9.87%	204,239 $15.1 Million
Q3 2023 Nov 03, 2023	SELL	$65.94 - $99.04 $2.07 Million - $3.11 Million	-31,383 Reduced 12.16%	226,596 $15.5 Million
Q2 2023 Aug 09, 2023	SELL	$62.68 - $95.05 $11 Million - $16.7 Million	-176,211 Reduced 40.58%	257,979 $24.2 Million
Q1 2023 May 09, 2023	SELL	$47.19 - $70.77 $2.61 Million - $3.91 Million	-55,233 Reduced 11.29%	434,190 $29.4 Million
Q4 2022 Feb 13, 2023	BUY	$30.35 - $53.15 $3.72 Million - $6.51 Million	122,490 Added 33.38%	489,423 $24.2 Million
Q3 2022 Oct 27, 2022	SELL	$31.97 - $49.37 $1.06 Million - $1.64 Million	-33,254 Reduced 8.31%	366,933 $11.9 Million
Q2 2022 Aug 01, 2022	SELL	$35.61 - $76.23 $2.83 Million - $6.06 Million	-79,457 Reduced 16.57%	400,187 $15.8 Million
Q1 2022 May 11, 2022	SELL	$57.56 - $82.54 $3.44 Million - $4.94 Million	-59,799 Reduced 11.09%	479,644 $33.5 Million
Q4 2021 Feb 11, 2022	BUY	$72.5 - $100.68 $9.69 Million - $13.5 Million	133,724 Added 32.96%	539,443 $42 Million
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $24.8 Million - $34.1 Million	274,904 Added 210.15%	405,719 $38.7 Million
Q2 2021 Aug 05, 2021	BUY	$93.66 - $139.27 $1.15 Million - $1.71 Million	12,268 Added 10.35%	130,815 $16.3 Million
Q1 2021 Apr 28, 2021	BUY	$116.57 - $155.01 $2.3 Million - $3.06 Million	19,761 Added 20.0%	118,547 $15.6 Million
Q4 2020 Feb 04, 2021	BUY	$99.61 - $142.12 $927,568 - $1.32 Million	9,312 Added 10.41%	98,786 $13.1 Million
Q3 2020 Nov 10, 2020	BUY	$72.92 - $102.01 $2.86 Million - $4 Million	39,204 Added 77.99%	89,474 $9.12 Million
Q2 2020 Aug 07, 2020	BUY	$55.75 - $92.75 $519,199 - $863,780	9,313 Added 22.74%	50,270 $4.37 Million
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $1.49 Million - $4.11 Million	-39,332 Reduced 48.99%	40,957 $2.38 Million
Q4 2019 Feb 04, 2020	SELL	$77.66 - $99.74 $1.77 Million - $2.27 Million	-22,731 Reduced 22.06%	80,289 $7.43 Million
Q3 2019 Nov 08, 2019	BUY	$90.37 - $122.49 $8,223 - $11,146	91 Added 0.09%	103,020 $9.31 Million
Q2 2019 Aug 13, 2019	SELL	$89.51 - $118.04 $601,775 - $793,582	-6,723 Reduced 6.13%	102,929 $12.2 Million
Q1 2019 May 08, 2019	BUY	$61.98 - $96.5 $30,122 - $46,899	486 Added 0.45%	109,652 $9.5 Million
Q4 2018 Feb 13, 2019	SELL	$56.04 - $82.66 $117,796 - $173,751	-2,102 Reduced 1.89%	109,166 $6.89 Million
Q3 2018 Nov 01, 2018	SELL	$48.29 - $80.6 $55,630 - $92,851	-1,152 Reduced 1.02%	111,268 $8.78 Million
Q2 2018 Aug 08, 2018	SELL	$37.84 - $69.96 $23.2 Million - $42.9 Million	-613,475 Reduced 84.51%	112,420 $6.72 Million
Q1 2018 May 08, 2018	SELL	$39.82 - $57.53 $41,572 - $60,061	-1,044 Reduced 0.14%	725,895 $29.3 Million
Q4 2017 Feb 02, 2018	SELL	$46.49 - $60.51 $173,407 - $225,702	-3,730 Reduced 0.51%	726,939 $38.2 Million
Q3 2017 Nov 13, 2017	BUY	$37.05 - $47.12 $27.1 Million - $34.4 Million	730,669	730,669 $34.4 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account